Covid-19 roundup: Moderna readies to enter PhIII in July, AstraZeneca not far behind; EU ready to negotiate vaccine access with $2.7B fund
Moderna may soon add another first to the Covid-19 vaccine race.
In March, the mRNA biotech was the first company to put a Covid-19 vaccine …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
